Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.03 USD | -3.33% | -6.02% | +15.34% |
Evolution of the average Target Price on Corvus Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Corvus Pharmaceuticals, Inc.
Oppenheimer | |
Ladenburg Thalmann | |
Cantor Fitzgerald | |
Jefferies & Co. | |
Mizuho Securities | |
HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- CRVS Stock
- Consensus Corvus Pharmaceuticals, Inc.